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Granuloma annular (GA) and necrobiosis lipoidica diabeti-
corum (NLD) are disorders characterized by granulomatous 
inflammation and degenerative changes in collagen and elas-
tic fibers. Because these disorders have often been described as 
being associated with altered extracellular matrix deposition, 
we studied the in situ expression of interstitial collagenase, 
92-kDa gelatinase, and tissue inhibitor of metalloproteinases 
(TIMP)-l. Twelve lesions each of GA and NLD of different 
histopathologic types and durations were examined. Intersti-
tial collagenase mRNA was seen in histiocyte-like cells in 
one-third of the cases of both diseases, typically in younger 
lesions. In GA, collagenase mRNA was only detected in le-
sions of the palisading type. Signal for 92-kDa gelatinase 
mRNA was observed in eosinophils, which were present in 
low numbers in five of 12 GA and three of 12 NLD samples. 
C hronic inflammatory conditions resulting in alter-ations of connective tissue are frequently associated with a local accumulation of phagocytic cells. Migra-tory cells influence the remodeling of extracellular matrix directly, by secreting various proteinases, and 
indirectly, by elaborating cytokines, such as interleukin-l and 
tumor necrosis factor-a. that may induce metalloproteinase gene 
expression in resident cells [1,2] . Beyond inflammatory reactions, 
the metalloproteinases participate in tissue remodeling during mor-
phogenesis, wound healing. implantation, uterine involution, and 
tumor invasion [3,4]. Among these enzymes, interstitial collagenase 
and 92-kDa gelatinase may have a coordinated role in matrix remod-
eling. Interstitial collagenase is produced by various cell types and 
has the unique abi li ty to cleave the triple helix of native, fibrillar 
collagen types I. II, and lll. as well as collagen types VII and X [5,6]. 
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TIMP-l: tissue inhibitor of metalloproteinases 1 
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The signal for this enzyme and the presence of eosinophils 
did not correlate with the age oflesion. TIMP-1 mRNA was 
consistently expressed by histiocyte-like cells in both disor-
ders. In GA, TIMP-1 mRNA was detected at the outer edge 
of the palisading granulomas, but in NLD, inhibitor expres-
sion was seen in the perivascular and periadnexal accumula-
tion of inflammatory cells. Our data indicate that collagenase 
and TIMP are expressed early in these disorders and that 
these proteins may contribute to stromal remodeling asso-
ciated with necrobiotic lesions. Our results further indicate 
that the localization of TIMP-1 production may provide a 
distinction between the two disorders, whereas metallopro-
teinase expression is not sufficiently specific to aid in the 
differential diagnosis of GA and NLD. ] Invest Dermato! 
100:335-342,1993 
The 92-kDa gelatinase degrades elastin [7], native types IV and V 
collagens. and denatured collagen or gelatin [8]. Thus, the degrada-
tion of fibrillar collagen is initiated by collagenase and possibly 
completed by 92-kDa gelatinase. III vitro studies have shown that 
many cell types produce 92-kDa gelatinase. including synovial fi-
broblasts [9]. cytotrophoblasts [10]' monocytes, and alveolar macro-
phage~ [11-13J.lt~ vivo ?emonstration of gelatinase expression has 
been hm.lted to eos1l10phlls [14] and the healing cornea [15], and the 
en~y~e IS also sto.red but ~ot actively made in neutrophils [16J. The 
actiVity o~ both 1I1terstltlal collagenase and 92-kDa gelatinase is 
re~ulated 111 part by the glycoprotein tissue inhibitor of metallopro-
telJ1ases (TIMP)-1 [17J. In some conditions. such as inflammatory 
arthropathies [18,19], interstitial collagenase and TIMP-1 are ex-
pressed by the same cel ls. but in other situations, such as pyogenic 
granuloma [20J and in resorbing tissues [21]. these proteins are 
produced separately. 
Granuloma annul are (GA) and necrobiosis lipoidica diabeticorum 
(NLD) are chronic skin diseases of unknown etiology and are char-
acterized by alterations in dermal collagen. In typical GA, the 
dermis contains focal collagen bundles exhibiting various degrees of 
apparent degeneration. These foci contain granular basophilic 
mucin deposits and are surrounded by palisades of histiocytes [22J . 
NLD is often associated with diabetes mellitus and is characterized 
by large, poorly defined areas of necrobiotic collagen; aggregations 
ofhistiocytes, fibroblasts, lymphocytes, and giant cells; extracellular 
lipid deposits; and vascular changes, including endothelial swelling, 
fibrosis, and hyalinization [23]. 
Clinical and pathologic differentiation of GA from NLD is made 
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Table I. Clinical Characteristics of 12 Patients with 





Age Biopsy Duration 
Sample Type' (years)' Location of Lesion' C TlMP-l G' 
1 P F/63 Neck 1 Week + + 
2 P M/52 Hand 10 Weeks + + E 
3 P F/53 Elbow 2 Months + + E 
4 D F/42 Elbow 3 Months + 
5 D F/2 Leg 5 Months + M 
6 P F/10 Leg 10 Months + + E 
7 D F/29 Leg 1 Year + M 
8 D F/26 Leg 2 Years + E 
9 P F/58 Leg 4 Years + E 
10 P M/39 Elbow 10 Years + 
11 D F/28 Elbow 15 Years + 
12 D F/78 Leg NA + 
• P, paJisadine; D, diffuse. 
• F, female; M, male. 
, Derived from patient history; for one sample, this information was not available 
(NA). 
J C, collagenase; G, 93-kDa gelatinase. 
, Signal for 92-kDa gelatinase mRNA was seen in either eosinophils (E) or in a few 
macrophages (M) or was not detected in any cell type (-). 
difficult because many of the histologic features seen in NLD are 
sometimes present in GA, and some reports have suggested that GA 
and NLD are part of the spectrum of the same disease [23]. Focal 
degeneration of collagen is the principal characteristic of both disor-
ders, and collagenolytic activity has been implicated in these disor-
ders [24] . Thus, we decided to assess the in situ expression of inter-
stitial collagenase . and TIMP-l in samples of GA and NLD. 
Changes in elastic fibers have also been associated with both diseases 
[22,23], and, hence, we also examined the expression of 92-kDa 
gelatinase. We report that TIMP- l was constitutively expressed in 
areas with abundant histiocytes in both diseases, whereas low levels 
of collagenase mRNA were seen in only a third of studied samples. 
Expression of 92-kDa gelatinase was typically found in eosinophils, 
which were present in the perivascular inflammatory infi ltrates of a 
few samples of both disorders . 
MATERIALS AND METHODS 
In Situ Hybridization Twelve samples each of formalin-fixed, 
paraffin embedded histologic specimens of GA and NLD were ob-
Table II. Clinical Characteristics of 12 Patients with 




Sample Type' (years)' 
1 N F/57 
2 I F/40 
3 G M/30 
4 G F/26 
5 N F/23 
6 G F/28 
7 N F/67 
8 I M/25 
9 I F/40 
10 N F/23 
11 N F/20 















Signal for mRNN 












• N, necrobiotic; G, granulomatous; I. or intermediate; all biopsy samples were 
taken from the leg. 
• F, female; M, male. 
, Derived from patient history; for two samples, this information was not available 
(NA). 
J C, collagenase; G, 92-kDa gelatinase. 
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tained from the Department of Pathology, Washington University 
School of Medicine. In addition, five samples of normal skin from 
different parts of the body were studied. Details of the technique 
have been published earlier [25]. All sections were treated with 1 
.ug/ml nuclease-free proteinase K (Sigma Chemical Co., St. Louis, 
MO) to loosen the constraints of intracellular cross-links caused by 
aldehyde fixation and were then washed in freshly prepared 0.1 M 
triethanolamine buffer containing 0.25% acetic anhydride to re-
duce potential non-specific binding sites . Sections were covered 
with 25 - 50 ,Ill hybridization buffer containing 50% deionized for-
mamide; 2 X standard saline citrate (SSe) buffer (1 X is 150 mM 
NaCl, 15 mM sodium citrate; pH 7.0); 20 mM Tris (hydroxy-
methyl) amino methane (Tris) - HCl (pH 8.0); 1 X Denhardt's solu-
tion; 1 mM ethylenediaminetetraacetic acid (EDT A); 10% dextran 
sulfate; 100 mM dithiothreitol (DTT); 0.5 mg/ml yeast tRNA; and 
2.5 X 104 cpm/.ul of 35S-labeled RNA probe; sections were then 
incubated at 55 0 C for 18 h. 
After hybridization, slides were washed under stringent condi-
tions, as described previously [25], except that 10 mM DDT was 
substituted for 25 mM p-mercaptoethanol in the wash solutions . 
The initial washes were in 4 X SSC and then in 0.5 X SSC for 15 
min each at ambient temperature. Non-specific binding was effec-
tively reduced by incubating slides in 0.5 M NaCI, 10 mM Tris-
HCl (pH 8.0), and 1 mM EDTA containing 20.ug/ml RNase-A 
(Sigma) at 37°C for 30 min. After RNase-A treatment, slides were 
washed sequentially in 2 X SSC for 30 min at ambient temperature, 
in 0.1 X SSC for 15 min at 60° C, and then in 0.1 X SSC for 30 min 
at room temperature. Washed slides were dipped in Kodak NTB-2 
emulsion prediluted 1 : 1 with distilled water and processed for auto-
radiography, as described previously [25]. After a 3 - 14-d autoradio-
graphic exposure, the photographic emulsion was developed-, and 
the slides were stained with hematoxylin - eosin. 
Preparation of RNA Probes A 550-bp EcoRV - Sma I fragment 
of the 5' end of human collagenase eDNA [26], a 313-bp Ace 1-
EcoRI fragment of the 5' end of human TIMP eDNA [27], and a 
560-bp BamHI - Xba I fragment of the 3' end of 92-kDa gelatinase 
eDNA [28] were subcloned into Bluescript KS transcription vectors 
(Stratagene, La Jolla, CA) . The constructs were linearized to allow 
transcription of antisense RNA from the fu ll length of the inserted 
fragments. As a control for non-specific hybridization, sections in 
each experiment were hybridized with 35S-labeled T77 -SP6, a 500-
nucleotide-sense RNA transcribed from a bovine tropoelastin 
eDNA. The validity of this probe as a negative control has been 
confirmed by Northern [25] and by in situ hybridization assays [20]. 
In vitro transcribed RNA was labeled with [a-35S]uridine-5' -tri-
phosphate (> 1200 Ci/mmol; NEN Products, Boston, MA) under 
conditions recommended by and with reagents from Promega (Mad-
ison, WI), except that the transcription reaction was extended to 4 h 
to allow for the relatively inefficient incorporation of sulfated ri-
bonucleotides. Calculated probe-specific activities were between 
108 and 109 dpm/.ug. The specificity of the collagenase, TIMP, and 
92-kDa gelatinase probes for the appropriate-sized mRNA has been 
demonstrated by Northern blot analysis under conditions similar to 
in situ hybridization [14,29]. 
Immunohistochemistry On sections parallel to those used for 
in situ hybridizations, tissue macrophages were identified by 
peroxidase - anti-peroxidase immunostaining using a monoclonal 
anti-macrophage antibody KP-l (Dako, product no. M814). As 
shown by others [30], this antibody reacts specifically with tissue 
macrophages. Endogenous peroxidase activity was blocked by incu-
bation with 0.3% H 20 2 for 30 min at room temperature. Sections 
were counterstained with Harris hematoxylin. 
RESULTS 
Tissues Twelve samples of histopathologically verified GA and 
12 lesions of NLD were studied. Seven of the 12 GA lesions had the 
classic pattern of histiocytes in palisades around distinct foci of al-
tered collagen [31]. The other five specimens represented the dif-
fuse type of GA characterized by narrow cords of degenerative col-
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Figure 1. Localization of collagenase mRNA in GA and NLD. Sections of GA (A-C) and NLD (D-F) were hybridized with an antisense 35S-labeled 
RNA probe for interstitial collagenase mRNA, as described in Materials and Methods. Autoradiographic exposure was for 10 d, and sections were stained 
with hematoxylin and eosin. (A,B) Paired bright- and dark-fiel~ ~hot~~crographs fr~m .a representative specimen of palisading GA. Centers of 
necrobiotic lesions, which are surrounded by palisades of Iymphohistiocytic mfiltrates, are mdicated (N). Autoradiographic signal for collagenase mRNA 
(arrows), which appears as white dots under dark-field illumination, is se~n adjacent to the palisades. (C) At higher magnifica tion, signal is seen in plump 
histiocyte-like cells (arrows) in areas between bundles of normal-appearmg collagen. (D,E) In NLD, collagenase mRNA (arrows indicate a few of these 
positive cells) was seen in cells associated with perivascular and peri adnexal inflammatory infiltrates (arrowheads). (F) At higher magnification, 
collagenase mRNA is seen in plump histiocyte-like cells (arrows) . (A,B,D,E) Bar, 45 J.lm; (C,F) bar, 11 J.lm. 
lagen in the dermis within areas of mucin ground substance 
deposition and by the presence of an interstitial and perivascular 
Iymphohistiocytic infiltrate. Six NLD lesions were of the necrobio-
tic type, three were granulomatous, and three were of the interme-
diate type [23] . Clinical characteristics of the patients are provided 
in Tables I and II. 
In Situ Hybridization Collagenase mRNA was detected in four 
of 12 GA lesions (Table I) and was seen predominantly in pale, 
plump histiocyte-like cells (Fig 1) and occasionally in spindle-
shaped fibroblast-like cells (data not shown). Collagenase-positive 
~ells wer~ only seen in GA of the palisading type; lesions represent-
mg the diffuse type were consistently negative (Table I). Further-
more, the cells that were positive for interstitial collagenase mRNA 
were seen in the dermal stroma and not within the palisading granu-
lomas. In NLD, the signal for collagenase mRNA was sporadic and 
remote from the necrobiotic areas. Four of 12 NLD lesions had 
collagenase mRNA-positive cells that appeared as histiocyte-like 
cells concentrated within infiltrates near blood vessels and sweat 
glands (Fig 1) and, in one specimen, within a granuloma. The pres-
ence of collagenase mRNA in NLD did not correlate with any 
specific histopathologic category (Table II) . In both disorders, gran-
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Figure 2_ Localization of 92-kDa gelatinase mRNA in GA and NLD; 
92-kDa gelatinase mRNA was expressed in GA (A) and NLD (B) by 
morphologically identifiable eosinophils within the lymphohistiocytic in-
filtrates (arrows indicate a few of these positive cells). (A) 5, sweat gland; 
bar, 45 j.lm; (B) V, vessel. The boxed areas in A and B approximate the area 
in the high-power micrographs in C and D, respectively. (C) Bar, 6 j.lm. 
Autoradiographic exposure was for 5 d. 
ulocytes and lymphocytes were consistently negative for interstitial 
collagenase. 
Autoradiographic signal for 92-kDa gelatinase mRNA was de-
tected in seven of 12 GA specimens within inflammatory infiltrates, 
but the positive cells were not adjacent to the palisading granulomas 
(Fig 2A,B). Eosinophils, identified by their characteristic staining 
and bilobar nuclear morphology, were the source of92-kDa mRNA 
in five of these cases (Table I). Two other GA samples were positive 
for 92-kDa mRNA, but the autoradiographic signal was minimal 
and present in just a few histiocyte-like cells within areas of perivas-
cular inflammatory infiltration (data not shown). Gelatinase 
mRNA was detected in only three of 12 NLD (Table II) samples 
and solely in eosinophils (Fig 2C,D). 
All GA samples and 11 of 12 NLD specimens displayed promi-
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nent autoradiographic signal for TIMP-1 mRNA (Tables I and II). 
In GA, TIMP-1 expression was seen in histiocyte-like cells located 
between individual collagen bundles within the areas of mucin dep-
osition or surrounding foci of necrobiosis at the outer edge of pali-
sading granulomas (Fig 3). Lymphocytes and granulocytes were 
consistently negative. In NLD, most TIMP-1-positive cells were 
histiocyte-like and were concentrated in the perivascular and peri-
adnexal infiltrate (Fig 4) . Signal was also present around granulomas 
and occasionally on the borders of necrobiotic areas. In two GA and 
five NLD samples, signal forTIMP-1 mRNA was detected in a few 
fibroblast-like cells. Giant cells and the interior of the granulomas 
were negative. 
In most GA and NLD samples, many of the cells with signal for 
collagenase and TIMP-1 mRNAs were seen in the same areas, but 
the number ofTIMP-1- positive cells was consistently greater than 
the number of collagenase-positive cells. In one of the four colla-
genase-positive GA samples, however, enzyme and TIMP-1 
mRNAs were found in separate locations. In this sample, collagen-
ase mRNA was located deep in the dermis in occasional macro-
phage-like cells, whereas TIMP-1-expressing cells were visualized 
at the outer edges of the palisades (data not shown). Similarly, in one 
specimen of NLD, collagenase mRNA was detected in stromal fi-
broblast-like cells, whereas TIMP-1 was seen in histiocyte-like cells 
surrounding necrobiotic collagen (data not shown). Signal for 
TIMP-1 did not co-localize with 92-kDa gelatinase mRNA in any 
speCimen. 
Sections hybridized with sense RNA probes had only background 
signal (data not shown). Five archival samples of normal skin from 
the face, arm, and leg were also hybridized with antisense probes for 
interstitial collagenase, 92-kDa gelatinase, and TIMP-1 mRNAs. 
Consistent with previous findings [14] and with expression limited 
to eosinophils [16], no signal for 92-kDa gelatinase mRNA was seen 
in any sample. Typically, no signal for collagenase mRNA was 
detected in normal skin, but in one of five samples, a few dermal 
fibroblasts expressed low levels of collagenase mRNA (data not 
shown). TIMP-1 expression was also seen in occasional fibroblasts 
and in some hair follicles and sebaceous glands, in agreement with 
previous studies [32]. The sporadic and minimal expression of colla-
genase or TIMP-1 in dermal fibroblasts contrasted with the far more 
prominent expression of these proteins observed in the GA and 
NLD samples described above. Furthermore, histiocyte-like cells, 
which were prominent in the disease specimens, and eosinophils 
were not seen in normal skin. 
Immunohistochemistry To assess the identity of the collagen-
ase- and TIMP-1-positive cells, we used immunostaining with a 
macrophage-specific antibody on serial sections of GA and NLD 
samples used for in situ hybridization. The morphology ofimmuno-
reactive macrophages in these samples included both spindle-
shaped and oval, plump cells (Fig 5). Furthermore, abundant, immu-
noreactive macrophages were seen in the same areas in' which 
collagenase and TIMP-1 mRNA-positive cells were detected (Fig 
5). These findings suggest that a subpopulation of macrophages was 
responsible for enzyme and inhibitor expression because there were 
many more immunoreactive cells than collagenase or TIMP-1 
mRNA-positive cells (Fig 5). 
DISCUSSION 
Our results demonstrate that TIMP-1 is consistently expressed by 
numerous cells in GA and NLD, whereas only low levels of mRNA 
for interstitial collagenase were seen in a few cells in one-third of the 
samples from both groups. In GA, TIMP-l mRNA was detected at 
outer edges of palisades and in areas of altered collagen between 
morphologically normal collagen bundles. In NLD samples, 
TIMP-1 mRNA was associated with the fibrohistiocytic infiltrate 
surrounding vessels and glands. The majority of cells possessing 
TIMP-l mRNA were pale, plump histiocyte-like cells that accu-
mulated around palisading granulomas and in mucinous areas be-
tween intact collagen bundles in GA specimens and were seen in 
perivascular and periadnexal infiltrates in NLD. Some spindle-
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Figure 3. Localization ofTIMP mRNA in GA. (A, B) In GA lesions of the palisading type, TIMP mRNA was detected at the outer edges of palisades, the 
extent of which are marked by arrolVS. (D,E) In GA samples of the diffuse type, numerous TIMP mRNA-positive cells were detected in areas of mucinous 
ground substance deposition between intact collagen bundles. (C, F) High-power images of the b.oxed areas from A and D, respectively, show that TIMP 
mRNA is present in plump histiocyte-like cells (arrows). In the diffuse GA sample, areas of muanous ground substance deposition are indicated (M). 
Autoradiographic exposure was for 7 d. (A, B, D, E) Bar, 45 f.lm; (C, F) bar, 11 f.lm . 
shaped, fibroblast-like cells were also positive for TIMP-l mRNA. 
All GA lesions that had signal for interstitial collagenase mRNA 
were of the palisading rype and were less than 1 year old when 
biopsied (Table I). 
Our findings suggest a possible role for collagenase early during 
the pathogenesis of necrobiotic changes. In palisading granulomas, 
degraded collagen was seen within the center of the lesions away 
from collagenase mRNA-positive cells. This spatial relationship 
suggests that degradation seen within the necrobiotic center oc-
curred earlier in the progression of the disease and that the sites of 
mRNA expression indicate areas of active collagenolysis at the time 
of the biopsy. Although our data involve detection of collagenase 
mRNA and do not demonstrate secretion of activated enzyme, 
many in vitro studies have confirmed that mRNA levels correlate 
with secret~d.collagenase protein levels [33,34]' and the use of both 
Immunostammg and ill situ hybridization has shown co-localization 
of92-~Da gelatinase protein and mRNA to eosinophils [16] . In fact, 
essentially ~ll studies of matrix metalloproteinase gene regulation 
have estabhshed pre-translational control mechanisms. 
Types I and III collagen synthesis are increased in fibroblasts 
surrounding the necrobiotic areas of GA [24] . Because we usually 
found TIMP-l expression in similar areas, inhibitor production 
may serv~ a~ a protective factor against collagenase activiry while 
new matrix IS depOSited . Theoretically, TIMP-l production may be 
a homeostatic response to collagenase expression during some stage 
of the disease. Upregulation of collagen and TIMP-l production 
suggests that a continuous process of regeneration is occurring in-
stead of mere collagenolysis . Alternatively, the function ofTIMP-
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D., 
Figure 4_ Localization of TIMP mRNA in NLD. (A, B) In NLD lesions of the necrobiotic type, TIMP mRNA-positive cells were seen in plump 
histiocyte-like cells in the areas of perivascular-periadnexal inflammatory infiltrate. (D, B) In lesions of the granulomatous type, most signal was 
detected in cells surrounding the granulomas (G). (C, F) High-power images of the boxed areas from A and D, respectively, show that TIMP mRNA is 
present in plump histiocyte-like cells (arrows) . Autoradiographic exposure was for 7 d. (A, B, D, B) Bar, 45 }lm; (C, F) bar, 11 }lm. 
I, in GA and NLD may be beyond its role as a metalloproteinase 
inhibitor, and its limited co-localization, both spatially and tempor-
ally, with collagenase mRNA supports this hypothesis. Although 
collagenase and TIMP are expressed by the same cells in burn 
wounds· and colorectal cancers [35], cellular production of these 
proteins is very distinct in colonic anastomosis [36] and in ulcerative 
pyogenic granulomas [20]. Furthermore, TIMP-l is mitogenic for 
numerous cells, suggesting that this glycoprotein might act as a 
growth factor in the pathogenesis of certain diseases [37]. 
• Jancic V, Liying L, Wenczak B, Nanney LB, Stricklin GP: Detection of 
collagenase and tissue inhibitor of metalloproteinases in healing human 
burn wounds by ill situ hybridization (abstr). J Invest Derrnatol 98:623, 
1992. 
Although the signal-mediating production ofTIMP-l in GA and 
NLD is not known, cytokines, such as transforming growth factor-
PI [38] or tumor necrosis factor-a [39]. may influence inhibitor 
expression. In a previous GA study, however, transforming growth 
factor-pI mRNA was not detected in the degenerative areas or in 
their surroundings [24]. which are the regions where we detected 
the most TIMP-l mRNA. It is possible that TIMP-l may be a 
constitutive product of a subpopulation of tissue macrophages or 
that its expression is influenced by other cytokines or by cell-cell or 
cell- matrix interactions. 
Signal for 92-kDa gelatinase mRNA was almost exclusively ex-
pressed in eosinophils that localized to perivascular and periadnexal 
infiltrates in only five of 12 GA and three of 12 NLD samples 
(Tables I and II) . These findings are consistent with previous results 
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Figure 5. Immunohistochemical staining of histiocytes. (A, B) Sections of GA ~er~ incub~t~d with a n;onoclo~al anti-macrophage antibody, KP-I, and 
were counterstained with Harris hematoxylin. Adjacent sections, processed for III Sltll hybndization for mterstitial collagenase (C) or TIMP-I (D) mRNA, 
are shown for comparison. Cells positive for interstitial collagenase (large a~rows) and TIMP-I (sma I! arrows) mRNA co-localized to the regions with 
abundant macrophages. In both sections, there were many more immunoreactive cells than mRNA-pOSltive cells. In C, some cOllagenase mRNA-positive 
cells were also seen in the follicular epithelium (arrowheads) . Bar, 23/1m. 
that indicate that eosinophils are the sole source of active production 
of 92-kDa gelatinase in inflammatory infiltrates associated with 
dermal neoplasms [14,16]. Both GA and NLD are characterized by 
degradation of elastic fibers in areas of marked necrobiosis [22,23]; 
however, 92-kDa gelatinase, which is also elastolytic [7], was not 
expressed in necrobiotic areas. These negative findings suggest that 
this enzyme does not participate in elastolysis or that the breakdown 
of elastic fibers by this enzyme is an early event in the pathogenesis 
of these disorders. 
Our findings do not indicate a characteristic pattern of expression 
for interstitial collagenase or 92-kDa gelatinase in either GA or 
NLD, and, thus, metall oproteinase expression may not provide a 
parameter for differential diagnosis of these closely related condi-
tions; however, our results do suggest that the production of these 
proteins is modulated during the maturation of the lesions. In both 
GA and NLD, collagenase expression was typically detected III 
younger lesions and absent in o lder lesions (Tables I and II), sug-
gesting that collagenolysis is a relatively early event during the 
course of these diseases. The expression of 92-kDa gelatinase did 
not correlate with age, and this, along with its expression in occa-
sional eosinophils, indicates that the activity of this enzyme may not 
be critical to the pathogenesis of GA and NLD. Tissue damage in 
these disorders, as well as in most conditions associated with matrix 
remodeling, probably results from the combined action of many 
distinct proteases, such as stromelysin-l, a metalloproteinase, and 
serine elastases, wh ich have broad substrate specificity. Expression 
of TIMP-l, on the other hand, was seen in nearly all samples, 
indicating an important role for this protein during the onset and 
progression of necrobiotic lesions. Furthermore, TIMP- t mRNA 
was detected in morphologically distinct areas in GA and NLD and 
these unique patterns of expression may provide a distinctio~ be-
tween these similar disorders . 
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